United States· US:0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b

TAZICEF

A medicinal product containing ceftazidime, registered in United States by Hospira, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTAZICEFATC—REGISTER NO.US:0409-5092_3f749ee0…PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CEFTAZIDIME
Manufacturer
Hospira, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    0409509216
    25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ceftazidime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidime products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
  • Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Bulgaria · Алфагем, Зидимцеф
  • Cyprus · Alfagem, Cezid
  • Czechia · Altecim, Ceftazidim Aptapharma
  • Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
  • Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Estonia · Altecim, Ceftazidime Fresenius Kabi
  • Spain · Alfagem, Ceftazidima Kabi
  • Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
  • United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
  • Greece · Alfagem, Ceftaridem
  • Croatia · Altecim, Cefaz
  • Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
  • Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
  • Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
  • Lithuania · Biotum, Ceftazidime Kabi
  • Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
  • Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
  • Malta · Alfagem, Ceftazidima Fresenius
  • Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
  • Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Poland · Biotum, Ceftazidim Aptapharma
  • Portugal · Alfagem, Ceftazidima Accord
  • Romania · Alfagem, Ceftamil
  • Sweden · Ceftazidim Hameln, Fortum
  • Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Slovakia · Ceftazidim Ash, Ceftazidim Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f430d0b6-72b5-4dab-824f-addd0bdcc4bb
GET /v1/drugs/f430d0b6-72b5-4dab-824f-addd0bdcc4bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "productid": "0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b",
  "productndc": "0409-5092",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "CEFTAZIDIME",
  "proprietary_name": "TAZICEF",
  "active_ingred_unit": "g/1",
  "application_number": "ANDA064032",
  "marketing_category": "ANDA",
  "nonproprietary_name": "CEFTAZIDIME",
  "start_marketing_date": "20060508",
  "active_numerator_strength": "1"
}

See everything about ceftazidime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.